Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
When the Digital Eclipse team at Konami boasted that they’d put a lot of care into the Teenage Mutant Ninja Turtles Cowabunga Collection I wrote it off as the standard marketing line we see around any ...
Has any pop culture franchise been through more permutations and reboots than Teenage Mutant Ninja Turtles? It doesn't help that so many of these projects are named simply "Teenage Mutant Ninja ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results